Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 USD | +4.42% | +31.76% | +21.58% |
Financials (USD)
Sales 2024 * | 76.43M | Sales 2025 * | 52.89M | Capitalization | 751M |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -141M | EV / Sales 2024 * | 7.71 x |
Net cash position 2024 * | 161M | Net cash position 2025 * | 67.89M | EV / Sales 2025 * | 12.9 x |
P/E ratio 2024 * |
-6.08
x | P/E ratio 2025 * |
-5.75
x | Employees | 267 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.82% |
Latest transcript on Wave Life Sciences Ltd.
1 day | +4.42% | ||
1 week | +31.76% | ||
Current month | +24.54% | ||
1 month | +3.37% | ||
3 months | +55.84% | ||
6 months | +8.87% | ||
Current year | +21.58% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 13-11-30 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 14-06-30 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 16-11-09 |
Mark Corrigan
BRD | Director/Board Member | 66 | 19-09-03 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 17-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 6.14 | +4.42% | 849,147 |
24-05-02 | 5.88 | +3.70% | 1,235,005 |
24-05-01 | 5.67 | +15.01% | 1,089,935 |
24-04-30 | 4.93 | +1.65% | 494,822 |
24-04-29 | 4.85 | +4.08% | 503,804 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.58% | 751M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- WVE Stock